C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele

Nephrology Dialysis Transplantation

Volumn 11, Issue 3, 1996, Pages 438-443

  Griffith, M E ^a   Lovegrove, J U ^b   Gaskin, G ^a   Whitehouse, D B ^b   Pusey, C D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alpha 1 antitrypsin; ANCA; Autoimmunity; Myeloperoxidase; Proteinase 3; Systemic vasculitis; Vasculitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBODY; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE;

ALLELE; ARTICLE; AUTOIMMUNITY; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; NEPHRITIS; PHENOTYPE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0029925466     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.3.438     Document Type: Article

References (42)

1. Esnault V, Testa A, Aucrain M et al. Alpha 1 antitrypsin genetic polymorphism in ANCA positive systemic vasculitis Kidney Int 1993; 43: 1329-1332
2. Elzouki AN, Segelmark M, Wieslander J, Eriksson S. Strong links between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994; 236: 543-548
3. O'Donaghue D, Guickian M, Blundell G, Winney R. Alpha 1 proteinase inhibitor and pulmonary haemorrhage in systemic vasculitis. In: Gross WL, ed. ANCA-Associaied Vasculitides: Immunological and Clinical Aspects. Plenum Press, New York, 1993; 331-335
4. Hagen EC, Balheux BE, van Es LA, Daha MR, van der Woude FJ. Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. (Review). Blood 1993; 81: 1996-2002
5. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D et al Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84: 1577-1587
6. Niles JL, McCluskey RT, Ahmad MF, Amin Arnaout M. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888-1893
7. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657
8. Kallenberg CGM, Cohea Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGKr, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 1991: 12: 61-64
9. Pusey CD, Gaskin G. Disease associations with anti-neutrophil cytoplasmic antibodies. In: Gross WL, ed. ANCA-Associated Vasculitides. Immunological and Clinical Aspects. Plenum Press, New York, 1993; 145-155
10. Cohen Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461-2465
11. Gaskin G, Savage COS, Ryan JJ et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689-694
12. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119
13. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 1992; 141 335-342
14. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3 the target autoantigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-1229
15. Savage COS, Gaskin G, Pusey CD, Pearson JD. Anti-neutrophil cytoplasmic antibodies (ANCA) can recognize vascular endothelial cell-bound ANCA-associated autoantigens. J Exp Nephrol 1993; 1. 190-195
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376
17. Dolman KM, van de Weil BA, Kam C-M et al. Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (C-ANCA) by dysregulation of the enzyme. In: Gross WL, ed. ANCA-Associated Vasculitides: Immunological and Clinical Aspects. Plenum Press, New York, 1993; 55-60
18. Hildesheim J, Kinsley G, Bissell M, Pierce J, Brantley M. Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha-1-antitrypsin deficiency variant P duarte. Hum Mutat 1993; 2: 221-228
19. Povey S. Genetics of alpha-1-antitrypsin deficiency in relation to neonatal liver disease. Mol Biol Med 1990; 7: 161-172
20. Carrell RW. Alpha-1-antitrypsin, molecular pathology, leucocytes, and tissue damage. J Clin Invest 1986; 78: 1427-1431
21. Curiel DT, Chytil A, Courtney M, Crystal RG. Serum alpha-1-antitrypsin deficiency associated with the common S-type (glu264-to-val) mutation results from intracellular degradation of alpha-1-antitrypsin prior to secretion. J Biol Chem 1989; 264: 10477-10486
22. Crystal RG. The alpha-1-antitrypsin gene and its deficient states. Trends Genet 1989; 5: 1427-1431
23. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
24. Lesavre P. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis 1991; 18: 159-163
25. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of anti-neutrophil cytoplasmic antibodies (ANCA). APMIS 1989; 97 [Suppl 6]: 12-13
26. Gaskin G, Kendal H, Coulthart A, Turner N, Pusey CD. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis. J Immunol Methods 1995; 180: 25-33
27. De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD. Relationship between disease activity and ANCA concentration by ELISA in long-term management of systemic vasculitis. Am J Kidney Dis 1995; 25: 380-389
28. Lee SS, Adu D, Thompson RA. Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol 1990; 79: 41-46
29. Whitehouse DB, Lovegrove JU, Hopkinson DA. Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Clin Chim Acta 1989; 179: 109-116
30. Phillips C, Whitehouse D. Advances in Forensic Haemogenetics. Springer-Verlag, Berlin, Heidelberg, 1990
31. Johnson PH, Cadiou H, Hopkinson DA. Detection of the common alpha-1-antitrypsin variants by denaturing gradient gel electrophoreseis. Ann Hum Genet 1991; 55: 183-198
32. Hagen EC, Andrassy K, Chernok E et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 1993; 159: 1-16
33. Thymann M. Distribution of alpha-1-antitrypsin (Pi) phenotypes in Denmark determined by separator isoelectric focusing in agarose gel. Hum Hered 1986; 36: 19-23
34. Hjalmarrson K. Distribution of alpha-1-antitrypsin phenotypes in Sweden. Hum Hered 1988; 38: 27-30
35. Santos Rosa MA, Robaldo Cordeiro AJ. Alpha-1-proteinase inhibitor phenotypes in the Portuguese population. Eur J Respir Dis 1986; 146: 167-173
36. Rasmussen N, Jayne DRW, Abramowicz D et al. European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 1995; 101 [Supplement]: 29-34
37. Henshaw TJ, Malone CC, Gabay JE, Williams RC. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1995; 37: 104-112
38. Cox DW, Huber O. Rheumatoid arthritis and alpha-1-antitrypsin. Lancet 1976; 1216-1217
39. Brewerton DA, Webley M, Murphy AH, Milford Ward A. The alpha 1 antitrypsin phenotype MZ in acute anterior uveitis. Lancet 1978; 1103
40. Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992; 41: 1059-1063
41. Zhang L, Jayne D, Zhao MH, Lockwood CM, Oliviera DBG. Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int 1995; 47: 294-298
42. Finn JE, Zhang Li, Agrawal S, Jayne DRW, Oliviera DBG, Mathieson PW. Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994; 9: 1564-1567